Back to Search
JOSEPH BLONSKI, MD
MD
Family Medicine Physician
NPI: 1316915325IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MN37949(MN)37949(MN)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
LOYOLA UNIVERSITY OF CHICAGO, STRITCH SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
The relationship of residency performance to match status and US versus international graduate status.
PMID 12607806·Fam Med·2003
4-observational
Is tolterodine (Detrol) or oxybutynin (Ditropan) the best for treatment of urge urinary incontinence?
PMID 11742595·J Fam Pract·2001
4-observational
Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia.
PMID 19125384·Leuk Lymphoma·2009
8-other
Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group.
PMID 19025975·Cancer·2009
8-other
Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia.
PMID 18676014·Leuk Res·2009
8-other
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.
PMID 17209059·Blood·2007
4-observational
Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphoma.
PMID 17577772·Leuk Lymphoma·2007
3-trial
In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and/or mitoxantrone.
PMID 17089066·Oncol Rep·2006
8-other
Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.
PMID 16948126·Cancer·2006
3-trial
Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2).
PMID 16551966·Blood·2006
4-observational
Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
PMID 16059649·Neoplasma·2005
8-other
The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
PMID 15996945·Haematologica·2005
2-rct
[Influence of transrectal endosonography on the clinical staging of impalpable prostate cancer. A controversy over the TNM system].
PMID 15045191·Urologe A·2004
3-trial
Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies.
PMID 15291352·Leuk Lymphoma·2004
3-trial
Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells.
PMID 14767525·Oncol Rep·2004
3-trial
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine.
PMID 14746857·Eur J Cancer·2004
8-other
Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging.
PMID 12885802·J Clin Oncol·2003
8-other
Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
PMID 12857600·Mediators Inflamm·2003
8-other
Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy?
PMID 12837427·Urology·2003
4-observational
Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction.
PMID 12705986·Eur Urol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1555 NORTHWAY DRIVE, SUITE 200
ST CLOUD, MN 56303 - Phone
- (320) 240-3157
Quick Facts
- NPI
- 1316915325
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile